Qube Research & Technologies (QRT)
BDSX icon

Qube Research & Technologies (QRT)’s Biodesix BDSX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,395
Closed -$42.5K – 3550
2025
Q1 		$42.5K Sell
3,395
-3,895
-53% -$74.8K ﹤0.01% 3140
2024
Q4 		$223K Buy
7,290
+3,668
+101% +$108K ﹤0.01% 2810
2024
Q3 		$129K Buy
3,622
+3,469
+2,267% +$119K ﹤0.01% 2692
2024
Q2 		$4.69K Sell
153
-3,322
-96% -$94.9K ﹤0.01% 3054
2024
Q1 		$99.4K Buy
3,475
+195
+6% +$6.67K ﹤0.01% 3299
2023
Q4 		$121K Buy
3,280
+2,962
+931% +$93K ﹤0.01% 3034
2023
Q3 		$10.5K Buy
+318
New +$8.83K ﹤0.01% 3302
2022
Q4 		– Sell
-681
Closed -$17K – 2466
2022
Q3 		$17K Sell
681
-103
-13% -$3.97K ﹤0.01% 2316
2022
Q2 		$26K Buy
+784
New +$25.5K ﹤0.01% 2232

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BDSX Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Biodesix (BDSX) in Q2 2025, closing a stake of 3,395 shares — an estimated $42.5K sold.

Qube Research & Technologies (QRT) first reported a position in BDSX in Q2 2022 and held it in 9 quarters. The position peaked at $223K in Q4 2024. 40 funds tracked by Wall St. Rank hold BDSX as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Biodesix position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 3,395 Biodesix shares in Q2 2025, an estimated $42.5K.
  • Qube Research & Technologies (QRT) first reported a position in Biodesix in Q2 2022 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Biodesix position peaked at $223K in Q4 2024.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.